Brue T, Rahabi H, Barry A, Barlier A, Bertherat J, Borson-Chazot F et al (2023) Position statement on the diagnosis and management of acromegaly: the French National Diagnosis and Treatment Protocol (NDTP). Ann Endocrinol (Paris) 84(6):697–710. https://doi.org/10.1016/j.ando.2023.08.003

Article  PubMed  Google Scholar 

Melmed S (2006) Medical progress: acromegaly. N Engl J Med 355(24):2558–2573. https://doi.org/10.1056/NEJMra062453

Article  CAS  PubMed  Google Scholar 

Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102–152. https://doi.org/10.1210/er.2002-0022

Article  CAS  PubMed  Google Scholar 

Maione L, Brue T, Beckers A, Delemer B, Petrossians P, Borson-Chazot F et al (2017) Changes in the management and comorbidities of acromegaly over three decades: the French acromegaly registry. Eur J Endocrinol 176(5):645–655. https://doi.org/10.1530/EJE-16-1064

Article  CAS  PubMed  Google Scholar 

Maione L, Chanson P (2019) National acromegaly registries. Best Pract Res Clin Endocrinol Metab 33(2):101264. https://doi.org/10.1016/j.beem.2019.02.001

Article  PubMed  Google Scholar 

Caron P, Brue T, Raverot G, Tabarin A, Cailleux A, Delemer B et al (2019) Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study. Endocrine 63(1):120–129. https://doi.org/10.1007/s12020-018-1764-4

Article  CAS  PubMed  Google Scholar 

Fleseriu M, Biller BMK, Freda PU, Gadelha MR, Giustina A, Katznelson L et al (2021) A Pituitary Society update to acromegaly management guidelines. Pituitary 24(1):1–13. https://doi.org/10.1007/s11102-020-01091-7

Article  PubMed  Google Scholar 

Fleseriu M, Fuhrer-Sakel D, van der Lely AJ, De Marinis L, Brue T, van der Lans-Bussemaker J et al (2021) More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY. Eur J Endocrinol 185(4):525–538. https://doi.org/10.1530/EJE-21-0239

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kerbel J, Cano-Zaragoza A, Espinosa-Dorado R, Garcia de la Torre KE, Mercado M. 2023 Real World Data on the Epidemiology, Diagnosis, and Treatment of Acromegaly: A Registries-based Approach. Arch Med Res. 54(6): 102856. https://doi.org/10.1016/j.arcmed.2023.102856

Albarel F, Castinetti F, Morange I, Conte-Devolx B, Gaudart J, Dufour H et al (2013) Outcome of multimodal therapy in operated acromegalic patients, a study in 115 patients. Clin Endocrinol (Oxf) 78(2):263–270. https://doi.org/10.1111/j.1365-2265.2012.04492.x

Article  CAS  PubMed  Google Scholar 

Micko AS, Wohrer A, Wolfsberger S, Knosp E (2015) Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. J Neurosurg 122(4):803–811. https://doi.org/10.3171/2014.12.JNS141083

Article  PubMed  Google Scholar 

Trouillas J, Roy P, Sturm N, Dantony E, Cortet-Rudelli C, Viennet G et al (2013) A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126(1):123–135. https://doi.org/10.1007/s00401-013-1084-y

Article  PubMed  Google Scholar 

Raverot G, Dantony E, Beauvy J, Vasiljevic A, Mikolasek S, Borson-Chazot F et al (2017) Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification. J Clin Endocrinol Metab 102(9):3368–3374. https://doi.org/10.1210/jc.2017-00773

Article  PubMed  Google Scholar 

Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, Freda PU (2010) Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf) 72(2):203–208. https://doi.org/10.1111/j.1365-2265.2009.03626.x

Article  PubMed  Google Scholar 

Dupuy O, Petrossian T, Bordier L, Mayaudon H, Bauduceau B (2007) Hypertension and acromegaly in the elderly: French registry data. Arch Mal Coeur Vaiss 100(8):660–663

CAS  PubMed  Google Scholar 

Bex M, Abs R, T’Sjoen G, Mockel J, Velkeniers B, Muermans K et al (2007) AcroBel–the Belgian registry on acromegaly: a survey of the “real-life” outcome in 418 acromegalic subjects. Eur J Endocrinol 157(4):399–409. https://doi.org/10.1530/EJE-07-0358

Article  CAS  PubMed  Google Scholar 

Arosio M, Reimondo G, Malchiodi E, Berchialla P, Borraccino A, De Marinis L et al (2012) Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol 167(2):189–198. https://doi.org/10.1530/EJE-12-0084

Article  CAS  PubMed  Google Scholar 

Mestron A, Webb SM, Astorga R, Benito P, Catala M, Gaztambide S et al (2004) Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 151(4):439–446. https://doi.org/10.1530/eje.0.1510439

Article  CAS  PubMed  Google Scholar 

Sesmilo G, Gaztambide S, Venegas E, Pico A, Del Pozo C, Blanco C et al (2013) Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA). Pituitary 16(1):115–121. https://doi.org/10.1007/s11102-012-0384-x

Article  PubMed  Google Scholar 

Kwon O, Song YD, Kim SY, Lee EJ (2013) Rare disease study group S, research committee KES nationwide survey of acromegaly in South Korea. Clin Endocrinol (Oxf). 78(4):577–85. https://doi.org/10.1111/cen.12020

Article  PubMed  Google Scholar 

Schofl C, Franz H, Grussendorf M, Honegger J, Jaursch-Hancke C, Mayr B et al (2013) Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly Register. Eur J Endocrinol 168(1):39–47. https://doi.org/10.1530/EJE-12-0602

Article  CAS  PubMed  Google Scholar 

Slagboom TNA, van Bunderen CC, De Vries R, Bisschop PH, Drent ML (2023) Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines. Pituitary 26(4):319–332. https://doi.org/10.1007/s11102-023-01322-7

Article  PubMed  PubMed Central  Google Scholar 

Castinetti F, Nagai M, Morange I, Dufour H, Caron P, Chanson P et al (2009) Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J Clin Endocrinol Metab 94(9):3400–3407. https://doi.org/10.1210/jc.2008-2772

Article  CAS  PubMed  Google Scholar 

Ghajar A, Jones PS, Guarda FJ, Faje A, Tritos NA, Miller KK et al (2020) Biochemical control in acromegaly with multimodality therapies: outcomes from a pituitary center and changes over time. J Clin Endocrinol Metab 105(3):e532–e543. https://doi.org/10.1210/clinem/dgz187

Article  PubMed  Google Scholar 

Nachtigall L, Delgado A, Swearingen B, Lee H, Zerikly R, Klibanski A (2008) Changing patterns in diagnosis and therapy of acromegaly over two decades. J Clin Endocrinol Metab 93(6):2035–2041. https://doi.org/10.1210/jc.2007-2149

Article  CAS  PubMed  Google Scholar 

Sandret L, Maison P, Chanson P (2011) Place of cabergoline in acromegaly: a meta-analysis. J Clin Endocrinol Metab 96(5):1327–1335. https://doi.org/10.1210/jc.2010-2443

Article  CAS  PubMed  Google Scholar 

Albarel F, Castinetti F, Morange I, Guibert N, Graillon T, Dufour H et al (2018) Pre-surgical medical treatment, a major prognostic factor for long-term remission in acromegaly. Pituitary 21(6):615–623. https://doi.org/10.1007/s11102-018-0916-0

Article  CAS  PubMed  Google Scholar